Clinical Cohort Study - Hamburg AoRtic Valve cOhoRt

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The primary aim of the study is to identify the optimal treatment modality for patients with aortic valve disease, incorporating the individual patient's risk profile and anticipated clinical outcomes. This includes the association of demographic factors, procedural data and biomarkers with clinical outcome in a prospective fashion.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with clinically relevant aortic valve disease (aortic valve stenosis, aortic regurgitation, degenerated aortic valve prosthesis)

• Written informed consent

Locations
Other Locations
Germany
Universitäres Herz- und Gefäßzentrum
RECRUITING
Hamburg
Contact Information
Primary
Moriz Seiffert, MD
m.seiffert@uke.de
+49407410
Backup
Niklas Schofer, MD
n.schofer@uke.de
+49407410
Time Frame
Start Date: 2019-09-01
Estimated Completion Date: 2049-09-01
Participants
Target number of participants: 15000
Related Therapeutic Areas
Sponsors
Leads: Universitätsklinikum Hamburg-Eppendorf

This content was sourced from clinicaltrials.gov